Corpus Intelligence IC Memo — PRINCETON BAPTIST MEDICAL CENTER 2026-04-26 06:39 UTC
IC Memo — PRINCETON BAPTIST MEDICAL CENTER
Investment Committee Memorandum | AL | 261 beds | Grade C | EBITDA uplift $15.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PRINCETON BAPTIST MEDICAL CENTER

CCN 010103 | JEFFERSON, AL | 261 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PRINCETON BAPTIST MEDICAL CENTER is a 261-bed suburban community hospital in JEFFERSON, AL with $216.3M in net patient revenue and a 2.3% operating margin. The hospital serves a payer mix of 17.2% Medicare, 17.4% Medicaid, and 65.4% commercial.

Thesis: Undervalued. Our ML models identify $15.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.3% to 9.7% (+736bps).

Net Revenue HCRIS$216.3M
Current EBITDA COMPUTED$5.0M
Operating Margin COMPUTED2.3%
Occupancy HCRIS58.6%
Revenue / Bed COMPUTED$829K
Net-to-Gross HCRIS10.4%
Distress Probability ML47.9%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
29
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of 2.3% places it above the state median. Among 29 size-comparable peers (130-522 beds), the median margin is -4.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (130-522), prioritizing same-state peers. 29 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PRINCETON BAPTIST MEDICAL CENT (Target)AL261$216.3M2.3%
THE CHILDRENS HOSPITAL OF ALABAL351$839.5M5.8%
GRANDVIEW MEDICAL CENTERAL404$615.4M14.2%
DCH REGIONAL MEDICAL CENTERAL372$601.9M-11.2%
BAPTIST MEDICAL CENTER SOUTHAL348$595.4M-4.8%
ST VINCENTS BIRMINGHAMAL399$480.0M-5.5%
SOUTHEAST HEALTH MEDICAL CENTEAL353$427.1M-4.4%
EAST ALABAMA MEDICAL CENTERAL297$399.6M-6.5%
USA HEALTH UNIVERSITY HOSPITALAL242$348.5M-6.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.5M+210bp18mo
Cost to Collect4.5%2.5%$4.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.6M+122bp9mo
Clean Claim Rate88.0%96.0%$138K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.5M
Cost to Collect
$4.3M
Denial Rate Reduction
$4.3M
A/R Days Reduction
$2.6M
Clean Claim Rate
$138K
Total EBITDA Uplift$15.9M
Current EBITDA$5.0M
+ RCM Uplift+$15.9M
Pro Forma EBITDA$20.9M
Current Margin2.3%
Pro Forma Margin9.7%
WC Released (1x)$8.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.6M$191.9M25.14x90.6%
Base (11x exit)10.0x11.0x$7.6M$213.6M27.97x94.7%
Bull Case9.0x11.0x$6.9M$268.6M39.09x108.2%
Bull (12x exit)9.0x12.0x$6.9M$295.1M42.94x112.1%
Bear Case11.0x10.0x$8.4M$109.9M13.08x67.2%
Bear (11x exit)11.0x11.0x$8.4M$123.6M14.71x71.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 29 hospitals with 130-522 beds
  • Same-state prioritization (n=30)
  • Comp margins: P25=-9.9% / P50=-4.8% / P75=0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.